SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-16-005213
Filing Date
2016-03-22
Accepted
2016-03-22 15:03:34
Documents
2
Period of Report
2016-03-21
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ecte8k_mar212016.htm 8-K 21839
2 PROMISSORY NOTE WITH PLATINUM PARTNERS VALUE ARBITRAGE FUND L.P. DATED MARCH 21, ex10-1.htm EX-10.1 17142
  Complete submission text file 0001415889-16-005213.txt   40533
Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 732-549-0919
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35218 | Film No.: 161520920
SIC: 3845 Electromedical & Electrotherapeutic Apparatus